Menu
Back to User profile » Professor Wolfgang Hohenforst-Schmidt
Papers published by Professor Wolfgang Hohenforst-Schmidt:
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity
Domvri K, Petanidis S, Zarogoulidis P, Anestakis D, Charalampidis C, Tsavlis D, Huang H, Freitag L, Hohenforst-Schmidt W, Matthaios D, Katopodi T, Porpodis K
International Journal of Nanomedicine 2022, 17:4449-4468
Published Date: 22 September 2022
A retrograde y-stenting of the trachea for treatment of mediastinal fistula in an unusual situation
Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Schneider T, Benhassen N, Rupprecht H, Freitag L
Therapeutics and Clinical Risk Management 2017, 13:655-661
Published Date: 23 May 2017
Second-line afatinib administration in an elderly patient with squamous cell carcinoma
Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Sardeli C, Stalikas N, Toitou M, Huang H
Therapeutics and Clinical Risk Management 2017, 13:341-343
Published Date: 20 March 2017
Video-assisted thoracic surgery reduces early postoperative stress. A single-institutional prospective randomized study
Asteriou C, Lazopoulos A, Rallis T, Gogakos AS, Paliouras D, Tsakiridis K, Zissimopoulos A, Tsavlis D, Porpodis K, Hohenforst-Schmidt W, Kioumis I, Organtzis J, Zarogoulidis K, Zarogoulidis P, Barbetakis N
Therapeutics and Clinical Risk Management 2016, 12:59-65
Published Date: 12 January 2016
Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report
Paliouras D, Gogakos A, Rallis T, Chatzinikolaou F, Asteriou C, Tagarakis G, Organtzis J, Tsakiridis K, Tsavlis D, Zissimopoulos A, Kioumis I, Hohenforst-Schmidt W, Zarogoulidis K, Zarogoulidis P, Barbetakis N
Therapeutics and Clinical Risk Management 2016, 12:1-4
Published Date: 21 December 2015
Reduction of exercise capacity in sarcoidosis in relation to disease severity
Kallianos A, Zarogoulidis P, Ampatzoglou F, Trakada G, Gialafos E, Pitsiou G, Pataka A, Veletza L, Zarogoulidis K, Hohenforst-Schmidt W, Petridis D, Kioumis I, Rapti A
Patient Preference and Adherence 2015, 9:1179-1188
Published Date: 18 August 2015
Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents
Hohenforst-Schmidt W, Linsmeier B, Zarogoulidis P,Freitag L, Darwiche K, Browning R, Turner JF, Huang H, Li Q, Vogl T, Zarogoulidis K, Brachmann J, Rittger H
Therapeutics and Clinical Risk Management 2015, 11:837-850
Published Date: 22 May 2015
DDMC-p53 gene therapy with or without cisplatin and microwave ablation
Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, Vogl T, Hübner F, Turner JF, Browning R, Zarogoulidis K, Drevelegas A, Drevelegas K, Darwiche K, Freitag L, Rittger H
OncoTargets and Therapy 2015, 8:1165-1173
Published Date: 20 May 2015
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses
Oezkan F, Khan AM, Zarogoulidis P, Hohenforst-Schmidt W, Theegarten D, Yasufuku K, Nakajima T, Freitag L, Darwiche K
OncoTargets and Therapy 2014, 7:2061-2065
Published Date: 10 November 2014
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Pitsiou G, Zarogoulidis P, Petridis D, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Papaiwannou A, Tsiouda T, Hohenforst-Schmidt W, Kakolyris S, Syrigos K, Huang H, Li Q, Turner JF, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1753-1763
Published Date: 7 October 2014
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
Zarogoulidis P, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Spyratos D, Pitsiou G, Petridis D, Pataka A, Huang H, Li Q, Yarmus L, Hohenforst-Schmidt W, Pezirkianidis N, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1065-1072
Published Date: 12 August 2014
“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome
Hohenforst-Schmidt W, Zarogoulidis P, Oezkan F, Mahnkopf C, Grabenbauer G, Kreczy A, Bartunek R, Darwiche K, Freitag L, Li Q, Huang H, Vogl T, LePilvert P, Tsiouda T, Tsakiridis K, Zarogoulidis K, Brachmann J
Therapeutics and Clinical Risk Management 2014, 10:207-215
Published Date: 27 March 2014
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K
Therapeutics and Clinical Risk Management 2014, 10:77-86
Published Date: 7 February 2014
Clinical experimentation with aerosol antibiotics: current and future methods of administration [Corrigendum]
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:121-122
Published Date: 16 January 2014
“One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology
Darwiche K, Zarogoulidis P, Krauss L, Oezkan F, Walter RFH, Werner R, Theegarten D, Sakkas L, Sakkas A, Hohenforst-Schmidt W, Zarogoulidis K, Freitag L
International Journal of Nanomedicine 2013, 8:4533-4542
Published Date: 22 November 2013
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D
OncoTargets and Therapy 2013, 6:1493-1500
Published Date: 22 October 2013
Clinical experimentation with aerosol antibiotics: current and future methods of administration
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K
Drug Design, Development and Therapy 2013, 7:1115-1134
Published Date: 2 October 2013
Vitamin D in asthma and future perspectives
Huang H, Porpodis K, Zarogoulidis P, Domvri K, Giouleka P, Papaiwannou A, Primikyri S, Mylonaki E, Spyratos D, Hohenforst-Schmidt W, Kioumis I, Zarogoulidis K
Drug Design, Development and Therapy 2013, 7:1003-1013
Published Date: 23 September 2013
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis
Hohenforst-Schmidt W, Petermann A, Visouli A, Zarogoulidis P, Darwiche K, Kougioumtzi I, Tsakiridis K, Machairiotis N, Ketteler M, Zarogoulidis K, Brachmann J
Drug Design, Development and Therapy 2013, 7:627-633
Published Date: 24 July 2013
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J
Drug Design, Development and Therapy 2013, 7:571-583
Published Date: 18 July 2013
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutspoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K
OncoTargets and Therapy 2013, 6:609-613
Published Date: 31 May 2013
New dilemmas in small-cell lung cancer TNM clinical staging
Zarogoulidis K, Latsios D, Porpodis K, Zarogoulidis P, Darwiche K, Antoniou N, Hohenforst-Schmidt W, Eleftheriadou E, Boutsikou E, Kontakiotis T
OncoTargets and Therapy 2013, 6:539-547
Published Date: 16 May 2013
Successful management of an inadvertent excessive treprostinil overdose
Hohenforst-Schmidt W, Hornig J, Friedel N, Zarogoulidis P, Zarogoulidis K, Brachmann J
Drug Design, Development and Therapy 2013, 7:161-165
Published Date: 21 March 2013
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K
OncoTargets and Therapy 2013, 6:125-134
Published Date: 1 March 2013
Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?
Hohenforst-Schmidt W, Riedel A, Zarogoulidis P, Franke C, Gschwendtner A, Huang H, Machairiotis N, Dramba V, Zarogoulidis K, Brachmann J
Drug Design, Development and Therapy 2012, 6:385-389
Published Date: 10 December 2012
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, Karamanos N, Zarogoulidis K
International Journal of Nanomedicine 2012, 7:1551-1572
Published Date: 22 March 2012